The global regenerative medicine market reached a value of US$ 11.94 Billion in 2020. Looking forward, the analyst expects the market to grow at a CAGR of 22.7% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Regenerative medicine refers to a branch of biomedical sciences aimed at restoring the structure and function of damaged tissues and organs. It involves the utilization of stem cells that are developed in laboratories and further implanted safely into the body for the regeneration of damaged bones, cartilage, blood vessels and organs. Cellular and acellular regenerative medicines are commonly used in various clinical therapeutic procedures, including cell, immunomodulation and tissue engineering therapies. They hold potential for the effective treatment of various chronic diseases, such as Alzheimer’s, Parkinson’s and cardiovascular disorders (CVDs), osteoporosis and spinal cord injuries.
The increasing prevalence of chronic medical ailments and genetic disorders across the globe is one of the key factors driving the growth of the market. Furthermore, the rising geriatric population, which is prone to various musculoskeletal, oncological, dermatological and cardiological disorders, is stimulating the market growth. In line with this, widespread adoption of organ transplantation is also contributing to the market growth. Regenerative medicine minimizes the risk of organ rejection by the body post-transplant and enhances the recovery speed of the patient. Additionally, various technological advancements in cell-based therapies, such as the development of 3D bioprinting techniques and the adoption of artificial intelligence (AI) in the production of regenerative medicines, are acting as other growth-inducing factors. These advancements also aid in conducting efficient dermatological grafting procedures to treat chronic burns, bone defects and wounds on the skin. Other factors, including extensive research and development (R&D) activities in the field of medical sciences, along with improving healthcare infrastructure, are anticipated to drive the market further.
Key Market Segmentation: the analyst provides an analysis of the key trends in each sub-segment of the global regenerative medicine market, along with forecasts at the global, regional and country level from 2021-2026. Our report has categorized the market based on type, application and end user.
Breakup by Type: Stem Cell Therapy Biomaterial Tissue Engineering Others
Breakup by Application: Bone Graft Substitutes Osteoarticular Diseases Dermatology Cardiovascular Central Nervous System Others
Breakup by End User: Hospitals Specialty Clinics Others
Breakup by Region: North America United States Canada Asia Pacific China Japan India South Korea Australia Indonesia Others Europe Germany France United Kingdom Italy Spain Russia Others Latin America Brazil Mexico Others Middle East and Africa
Competitive Landscape: The report has also analysed the competitive landscape of the market with some of the key players being Allergan PLC (AbbVie Inc.), Amgen Inc., Baxter International Inc., BD (Becton, Dickinson and Company), Integra Lifesciences Holdings Corporation, Medtronic plc, Mimedx Group Inc., Novartis AG, Osiris Therapeutics Inc. (Smith & Nephew plc) and Thermo Fisher Scientific Inc. Key Questions Answered in This Report: How has the global regenerative medicine market performed so far and how will it perform in the coming years? What has been the impact of COVID-19 on the global regenerative medicine market? What are the key regional markets? What is the breakup of the market based on the type? What is the breakup of the market based on the application? What is the breakup of the market based on the end user? What are the various stages in the value chain of the industry? What are the key driving factors and challenges in the industry? What is the structure of the global regenerative medicine market and who are the key players? What is the degree of competition in the industry?
Our reports have been used by over 10K customers, including:
The Global Microbiome Partnering Terms and Agreements 2010 to 2021 report provides an understanding and access to the Microbiome partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in Microbiome partnering deals Disclosed headlines, upfronts, milestones and royalties by...
The Global Stem Cell Partnering Terms and Agreements 2010-2021 report provides comprehensive understanding and unprecedented access to the stem cell partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in stem cell partnering Deal terms analysis Partnering agreement structure Partnering...
Global Coronavirus Partnering 2014 to 2021 provides the full collection of Coronavirus disease deals signed between the world’s pharmaceutical and biotechnology companies since 2014. Trends in Coronavirus partnering deals Financial deal terms for headline, upfront and royalty by stage of development Coronavirus...
Biopharmaceutical Fermentation Systems market is one of the high-growth prospect industries with potential opportunities throughout 2028. The Biopharmaceutical Fermentation Systems Market growth analysis and insights report analyzes emerging market trends, market size outlook, potential opportunities, market share by Biopharmaceutical Fermentation...
The global pharmaceutical CMO market was valued at USD 120.29 billion in 2020, and it is expected to reach USD 195.70 billion by 2026, registering a CAGR of 7.85% from 2021 to 2026. COVID-19 pandemic has had a beneficial effect on contract manufacturing services overall. There were multiple opportunities for CMOs in clinical trial manufacturing,...
Global Hospital Care Partnering 2014 to 2021 provides the full collection of Hospital Care disease deals signed between the world’s pharmaceutical and biotechnology companies since 2014. Trends in Hospital Care partnering deals Financial deal terms for headline, upfront and royalty by stage of development Hospital...
120 pages •
By Infiniti Research Limited
• Nov 2021
Global BioPharma Cold Chain Packaging Market 2021-2025 The analyst has been monitoring the biopharma cold chain packaging market and it is poised to grow by $ 1.85 bn during 2021-2025, progressing at a CAGR of 9.24% during the forecast period. Our report on the biopharma cold chain packaging market provides a holistic analysis,...
The Global Biosimilars Partnering Terms and Agreements 2010 to 2021 report provides an understanding and access to the Biosimilars partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in Biosimilars partnering deals Disclosed headlines, upfronts, milestones and royalties...
The global oxidative stress assay market reached a value of US$ 836 Million in 2020. Looking forward, the analyst expects the market to grow at a CAGR of 9.7% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the...
The global propionic acid market grew at a CAGR of around 8% during 2015-2020. Propionic acid (PA) refers to a naturally occurring colorless and corrosive carboxylic acid. It is produced by the chemical reaction of carbon monoxide and water and consists of a short-chain saturated fatty acid attached to a carboxyl carbon....
Research And Development
Biologics Penetration Rate
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.